AMENDMENT NO. 2 TO SCHEDULE 13D
This amendment to Schedule 13D is being filed by Spruce House Investment Management LLC (the “Investment Manager”), Spruce House Capital LLC (the “General Partner”), The Spruce House Partnership LP (the “Fund”), Zachary Sternberg and Benjamin Stein (the “Managing Members”) (collectively, the “Reporting Persons”, and each, a “Reporting Person”).
The Schedule 13D (the “Schedule”) filed with the Securities and Exchange Commission on December 26, 2018, as amended by Amendment No. 1 filed on January 27, 2019, is hereby amended and supplemented by the Reporting Persons as set forth below in this Amendment No. 2. This amendment is filed by the Reporting Persons in accordance with Rule13d-2 of the Securities Exchange Act of 1934, as amended, and refers only to information that has materially changed since the filing of the Schedule 13D. The items identified below, or the particular paragraphs of such items which are identified below, are amended as set forth below. Unless otherwise indicated, all capitalized terms used and not defined herein have the respective meanings assigned to them in the Schedule.
Except as specifically amended by this Amendment No. 2, the Schedule 13D is unchanged.
Item 3 | Source and Amount of Funds or Other Considerations |
The disclosure in Item 3 is hereby amended to add the following to the end thereof:
The information set forth in item 5(c) of this amendment to Schedule 13D is incorporated herein by reference. Such purchases were funded using working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business).
Item 4 | Purpose of Transaction |
The disclosure in Item 4 is hereby amended to add the following to the end thereof:
On April 22, 2019, the Company announced that it amended its bylaws to, among other things, increase the size of its Board from nine to ten directors. The Company also announced that it intends to nominate Benjamin Stein, a representative of the Fund and a Reporting Person, for election to its Board at its 2019 annual meeting of stockholders to fill the newly created vacancy. The Company further announced that it plans to extend an invitation to Zachary Sternberg, also a representative of the Fund and a Reporting Person, to serve as a Board observer, subject to the election of Mr. Stein to the Board at the 2019 annual meeting.
The transactions described in Item 5(c) below were effectuated for investment purposes in the regular course of such entity’s business.
Item 5 | Interest in Securities of the Issuer |
The disclosure in Items 5(a) and 5(b) is hereby amended and restated in its entirety to read as follows:
(a) and (b) The responses of each of the Reporting Persons with respect to Rows 11, 12, and 13 of the cover pages of this Schedule 13D that relate to the aggregate number and percentage of common stock (including but not limited to footnotes to such information) are incorporated herein by reference.
The responses of each of the Reporting Persons with respect to Rows 7, 8, 9, and 10 of the cover pages of this Schedule 13D that relate to the number of common stock as to which each of the persons or entities referenced in Item 2 above has sole or shared power to vote or to direct the vote of and sole or shared power to dispose of or to direct the disposition of (including but not limited to footnotes to such information) are incorporated herein by reference.
The reported securities are held in the account of the Fund, a private investment fund managed by the Investment Manager, and may be deemed to be beneficially owned by the Investment Manager, the General Partner of the Fund, and by the Managing Members of the Investment Manager and the General Partner. Each of the Investment Manager, the General Partner, and the Managing Members expressly disclaims beneficial ownership of the shares held by the Fund.
The disclosure in Item 5(c) of the Schedule 13D is hereby supplemented by adding the following at the end thereof:
On January 18, 2019, the Fund purchased 40,403 shares of Common Stock of the Issuer at a weighted average price of $26.73 per share1 in open market transactions.
On January 18, 2019, the Fund purchased 94,597 shares of Common Stock of the Issuer at a weighted average price of $27.50 per share2 in open market transactions.